Secondary resection in a general mCRC population with cetuximab-based first-line treatment – Interim analysis of the German noninterventional study ERBITAG Posted on 1. Februar 201319. Mai 2017 by friebelwv Autoren: Overkamp F., Göhler T.; Reich G., Schwerdtfeger M., Stübs P., Stenzel KG., and Neumann UP. ASCO-GI 2013
